The stock of InfuSystem Holdings Inc (NYSEMKT:INFU) hit a new 52-week low and has $1.76 target or 12.00% below today’s $2.00 share price. The 7 months bearish chart indicates high risk for the $47.93M company. The 1-year low was reported on Nov, 7 by Barchart.com. If the $1.76 price target is reached, the company will be worth $5.75M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 97,806 shares traded hands or 311.40% up from the average. InfuSystem Holdings Inc (NYSEMKT:INFU) has declined 22.39% since April 5, 2016 and is downtrending. It has underperformed by 24.34% the S&P500.
Analysts await InfuSystem Holdings Inc (NYSEMKT:INFU) to report earnings on November, 10.
According to Zacks Investment Research, “InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management.”
Insitutional Activity: The institutional sentiment decreased to 1.5 in Q2 2016. Its down 1.17, from 2.67 in 2016Q1. The ratio fall, as 5 funds sold all InfuSystem Holdings Inc shares owned while 5 reduced positions. 3 funds bought stakes while 12 increased positions. They now own 9.32 million shares or 1.31% less from 9.44 million shares in 2016Q1.
Tower Rech Lc (Trc) last reported 0% of its portfolio in the stock. Dimensional Fund Lp reported 117,503 shares or 0% of all its holdings. Deutsche Bank Ag holds 119,731 shares or 0% of its portfolio. Community Fincl Bank Na holds 0.01% or 12,000 shares in its portfolio. The North Carolina-based Salem Invest Counselors has invested 0% in InfuSystem Holdings Inc (NYSEMKT:INFU). Bridgeway Cap Inc last reported 326,078 shares in the company. Lsv Asset Mgmt holds 332,391 shares or 0% of its portfolio. Rbf Limited Liability Company holds 0.52% or 1.01 million shares in its portfolio. Federated Inc Pa has 0% invested in the company for 159 shares. Greenwood Invs Incorporated owns 1.68 million shares or 8.08% of their US portfolio. Clifford Swan Invest Counsel reported 21,000 shares or 0% of all its holdings. Gabelli Funds Ltd, a New York-based fund reported 168,458 shares. California Pub Employees Retirement accumulated 23,800 shares or 0% of the stock. Ativo Capital Management Limited Liability Corporation last reported 0.14% of its portfolio in the stock. Weber Alan W holds 58,400 shares or 0.11% of its portfolio.
Insider Transactions: Since September 1, 2016, the stock had 4 insider purchases, and 0 sales for $176,434 net activity. Morris Ryan J. had bought 23,171 shares worth $66,111.
More recent InfuSystem Holdings Inc (NYSEMKT:INFU) news were published by: Quotes.Wsj.com which released: “News InfuSystems Holdings Inc.INFU” on February 11, 2011. Also Businesswire.com published the news titled: “InfuSystem Holdings, Inc. Names Janet Skonieczny Chief Operating Officer” on January 02, 2013. Businesswire.com‘s news article titled: “InfuSystem Holdings, Inc. Names Eric Steen Chief Executive Officer; Interim …” with publication date: March 14, 2013 was also an interesting one.
INFU Company Profile
InfuSystem Holdings, Inc., incorporated on August 15, 2005, is a well-known provider of infusion pumps and related services and products for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Firm delivers local, field customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. The Company’s core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states (Oncology Business). In addition, the Company sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others. The Firm also provides these services and products to clients in the hospital market. The Firm repairs, refurbishes and provides biomedical certification for the devices as needed. The Firm operates through subsidiaries, including InfuSystem Holdings USA, Inc. (Holdings), InfuSystem, Inc. (ISI), First Biomedical, Inc. (First Biomedical) and IFC, LLC (IFC).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.